Results for announcement to the market
Name of issuer Barramundi Limited
Reporting Period 6 months to 31 December 2023
Previous Reporting Period 6 months to 31 December 2022
Currency NZ$
Amount (000s) Percentage change
Revenue from continuing operations $19,667 +29%
Total Revenue $19,667 +29%
Net profit/(loss) from continuing operations $17,027 +39%
Total net profit/(loss) $17,027 +39%
Interim/Final Dividend
Amount per Quoted Equity Security $NZ 1.45 cents per share
Imputed amount per Quoted Equity Security $NZ 0.00006534
Record Date 7 March 2024
Dividend Payment Date 28 March 2024
Current period Prior comparable period
Net tangible assets per Quoted Equity Security $0.7532 $0.6544
A brief explanation of any of the figures above necessary to enable the figures to be understood The financial statements attached to this report have been reviewed by PricewaterhouseCoopers and are not subject to a qualification. A copy of the auditor’s review report applicable to the financial statements is attached to this announcement.
Authority for this announcement
Name of person authorised to make this announcement W.A. Burns
Contact person for this announcement W.A. Burns
Contact phone number (09) 4840352
Contact email address [email protected]
Date of release through MAP 21 February 2024
Reviewed interim financial statements accompany this announcement.
Auckland surgical products company is forecasting annual profit of between $2m to $6m.
The cancer diagnostics company is awaiting outcomes of several events.
Software firm won't pay dividend as it plans for more growth in consolidating markets.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details